Sanara MedTech (NASDAQ:SMTI – Get Rating) is scheduled to announce its earnings results after the market closes on Monday, May 16th. Investors that are interested in registering for the company’s conference call can do so using this link.
Shares of NASDAQ:SMTI opened at $22.04 on Monday. The company’s 50-day moving average is $26.88. Sanara MedTech has a 12-month low of $18.85 and a 12-month high of $43.89. The company has a market capitalization of $174.23 million, a PE ratio of -20.41 and a beta of 2.24.
SMTI has been the subject of several analyst reports. Zacks Investment Research upgraded Sanara MedTech from a “sell” rating to a “hold” rating in a report on Wednesday, February 2nd. Cantor Fitzgerald reissued an “overweight” rating on shares of Sanara MedTech in a research note on Monday, May 2nd.
About Sanara MedTech (Get Rating)
Sanara MedTech Inc develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution.
- Get a free copy of the StockNews.com research report on Sanara MedTech (SMTI)
- ChemoCentryx: A Biotech Stock Well Worth the Risk
- Skechers Stock Can Be Bought on Pullbacks
- Nasdaq Stock is a Buy the (Deep) Dip Opportunity
- Three Stocks To Ride Out A Rough Market
- MarketBeat: Week in Review 5/2 – 5/6
Receive News & Ratings for Sanara MedTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanara MedTech and related companies with MarketBeat.com's FREE daily email newsletter.